Ursprung des Netzwerks ersten Grades von Bob Mecca
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Public Company | Pharmaceuticals: Major | 17 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Bob Mecca
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
The University of Chicago | College/University | Doctorate Degree Masters Business Admin | |
The Pennsylvania State University | College/University | Graduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals Corp.
Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
YUM! BRANDS, INC. | Restaurants | Chairman | |
Millennium Pharmaceuticals, Inc.
Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Henley Management College | College/University | Masters Business Admin | |
University of Bath | College/University | Undergraduate Degree | |
KALEIDO BIOSCIENCES, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
858 Therapeutics, Inc.
858 Therapeutics, Inc. BiotechnologyHealth Technology 858 Therapeutics, Inc. operates as a pharmaceutical company. The company was founded in 2019 and is headquartered in San Diego, CA. | Biotechnology | Director/Board Member | |
PRELUDE THERAPEUTICS INCORPORATED | Biotechnology | President | |
PROTARA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Corporate Officer/Principal | |
Acerta Pharma BV
Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Acerta Pharma BV develops drugs for oncology and autoimmune diseases. It operates as a biotech company that combines technology platforms in drug discovery and development such as the covalent technology platform and the multiparametric phosphoflow cytometry platform. The company was founded by Allard Kaptein in 2012 and is headquartered in Oss, Netherlands. | Pharmaceuticals: Generic | Corporate Officer/Principal | |
Stanford University | College/University | Undergraduate Degree | |
Washington University School of Medicine | College/University | Doctorate Degree | |
Norman Bethune Medical University | College/University | Doctorate Degree | |
Cancer International Research Group | Founder | ||
Breast Cancer International Research Group Ltd. | Founder | ||
NOVARTIS AG | Pharmaceuticals: Major | Corporate Officer/Principal | |
Intima Bioscience, Inc.
Intima Bioscience, Inc. Pharmaceuticals: MajorHealth Technology Intima Bioscience, Inc. is a bioscience company that is advancing checkpoint cell therapy for solid tumors with curative intent. The private company is based in New York, NY. The company combines the use of patients' own immune cells with immune checkpoint targeting. Intima is currently running a phase 1/2 clinical study of its checkpoint cell therapy, which targets the immune checkpoint cish in patients with gastrointestinal and colon cancers. Alessandro Riva has been the CEO of the company since 2021. | Pharmaceuticals: Major | Chief Executive Officer | |
TRANSGENE | Biotechnology | Chief Executive Officer | |
CENTURY THERAPEUTICS, INC. | Biotechnology | Director/Board Member | |
University of Milan | College/University | Doctorate Degree | |
GRITSTONE BIO, INC. | Biotechnology | Director/Board Member | |
Eight Roads Capital Advisors (CHINA) | Investment Managers | Private Equity Investor | |
University of California San Diego | College/University | Masters Business Admin | |
University of Pittsburgh School of Medicine | College/University | Doctorate Degree | |
C4 THERAPEUTICS, INC. | Biotechnology | Comptroller/Controller/Auditor | |
Norwich University | College/University | Undergraduate Degree | |
Carnegie Mellon University
Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Masters Business Admin | |
SIGILON THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer | |
PFIZER, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
SANOFI | Biotechnology | Corporate Officer/Principal | |
Cornell University
Cornell University Other Consumer ServicesConsumer Services Cornell University is an educational institution that offers undergraduate and post graduate programs. It was founded in 1865 and is based in Ithaca, NY. | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Graduate Degree | |
ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal | |
GLENMARK PHARMACEUTICALS LIMITED | Pharmaceuticals: Major | Corporate Officer/Principal | |
SCHRÖDINGER, INC. | Packaged Software | Chief Tech/Sci/R&D Officer | |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Wyeth Holdings LLC
Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. | Chemicals: Agricultural | Corporate Officer/Principal | |
New York University | College/University | Doctorate Degree | |
Dracen Pharmaceuticals, Inc.
Dracen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Dracen Pharmaceuticals, Inc. develops immuno-metabolism drugs. The company was founded by Barbara Slusher, Jonathan D. Powell, Pavel Majer, and Rana Rais and is headquartered in New York, NY. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
AGIOS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
ATARA BIOTHERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
University of Freiburg | College/University | Doctorate Degree | |
CORBUS PHARMACEUTICALS HOLDINGS, INC. | Pharmaceuticals: Major | Director/Board Member | |
BIOATLA, INC. | Biotechnology | Corporate Officer/Principal | |
Ichnos Sciences, Inc.
Ichnos Sciences, Inc. Miscellaneous Commercial ServicesCommercial Services Ichnos Sciences, Inc. operates as a biotechnology company. It provides curative therapies that extend human life. The company was founded in 2019 and is headquartered in Paramus, NJ. | Miscellaneous Commercial Services | Chief Executive Officer |
Statistik
International
Vereinigte Staaten | 38 |
Vereinigtes Königreich | 4 |
China | 3 |
Frankreich | 3 |
Niederlande | 2 |
Sektoral
Health Technology | 27 |
Consumer Services | 18 |
Technology Services | 3 |
Finance | 2 |
Process Industries | 2 |
Operativ
Corporate Officer/Principal | 32 |
Director/Board Member | 31 |
Independent Dir/Board Member | 17 |
Undergraduate Degree | 12 |
President | 9 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Yung Cheng Chen | 26 |
Alessandro Riva | 14 |
Howard Liang | 12 |
sam Su | 10 |
Jane Huang | 8 |
Margaret Dugan | 7 |
Clare Fisher | 6 |
Yong Ben | 6 |
Chan Lee | 5 |
Bernd Kullmann | 5 |
Kevin C. Mannix | 4 |
Christiane Langer | 4 |
Mark Lanasa | 4 |
Julius Pryor | 3 |
Mark Mossler | 3 |